Euclidean Capital LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001825034 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $118M (100.0% shares, 0.0% debt)

Holdings (10)

PMVP PMV PHARMACEUTICALS INC 28.3%

Value $33.3M Shares 2,336,909 Est. Cost $39.23 Unrealized -62.9%

— 23ANDME HOLDING CO 21.6%

Value $25.4M Shares 10,243,122 Est. Cost $3.83 Unrealized —

FHTX FOGHORN THERAPEUTICS INC 14.6%

Value $17.15M Shares 1,261,261 Est. Cost $19.16 Unrealized -32.6%

ALEC ALECTOR INC 8.5%

Value $9.966M Shares 980,894 Est. Cost $12.43 Unrealized -19.7%

— NGM BIOPHARMACEUTICALS INC 8.1%

Value $9.572M Shares 746,674 Est. Cost $30.30 Unrealized —

— RAPT THERAPEUTICS INC 6.7%

Value $7.9M Shares 432,900 Est. Cost $19.75 Unrealized —

TNYA TENAYA THERAPEUTICS INC 4.4%

Value $5.155M Shares 915,705 Est. Cost $21.49 Unrealized -62.3%

FFBC FIRST FINL BANCORP OH 2.9%

Value $3.367M Shares 173,576 Est. Cost $12.77 Unrealized +40.8%

ORIC ORIC PHARMACEUTICALS INC 2.8%

Value $3.349M Shares 747,550 Est. Cost $28.69 Unrealized -86.1%

— SURROZEN INC 2.0%

Value $2.409M Shares 802,963 Est. Cost $7.08 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PMVP	PMV PHARMACEUTICALS INC	2,336,909	$33.3M	28.3%	$39.23	-62.9%	COM	69353Y103
—	23ANDME HOLDING CO	10,243,122	$25.4M	21.6%	$3.83	—	CLASS A COM	90138Q108
FHTX	FOGHORN THERAPEUTICS INC	1,261,261	$17.15M	14.6%	$19.16	-32.6%	COM	344174107
ALEC	ALECTOR INC	980,894	$9.966M	8.5%	$12.43	-19.7%	COM	014442107
—	NGM BIOPHARMACEUTICALS INC	746,674	$9.572M	8.1%	$30.30	—	COM	62921N105
—	RAPT THERAPEUTICS INC	432,900	$7.9M	6.7%	$19.75	—	COM	75382E109
TNYA	TENAYA THERAPEUTICS INC	915,705	$5.155M	4.4%	$21.49	-62.3%	COM	87990A106
FFBC	FIRST FINL BANCORP OH	173,576	$3.367M	2.9%	$12.77	+40.8%	COM	320209109
ORIC	ORIC PHARMACEUTICALS INC	747,550	$3.349M	2.8%	$28.69	-86.1%	COM	68622P109
—	SURROZEN INC	802,963	$2.409M	2.0%	$7.08	—	COM	86889P109